CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that Harvey J. Berger, M.D., chairman and chief executive officer, and Timothy P. Clackson, Ph.D., president of research and development and chief scientific officer, will provide an overview of the Company’s business at two upcoming investor conferences:
